BIVI - Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against BioVie Inc. (BIVI) | Benzinga

NEW YORK, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Nevada on behalf of all persons or entities who purchased or otherwise acquired BioVie Inc. ("BioVie" or the "Company") (NASDAQ:BIVI) securities between August 5, 2021 and November 29, 2023, inclusive (the "Class Period").

The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (i) the ongoing COVID-19 pandemic caused "limited access" to clinical trial sites, significantly affecting BioVie's ability to conduct proper oversight of the clinical trial; (ii) due to the "limited access" to the clinical trial sites, the trial was at higher risk of having "significant deviation from protocol and Good Clinical Practice (GCP) violations" and "anomalous data"; (iii) BioVie was experiencing issues with the contract research organizations it had retained, creating greater ...

BIVI)>Full story available on Benzinga.com